White paper on peanut allergy - part 1: Epidemiology, burden of disease, health economic aspects

Allergo J Int. 2021;30(8):261-269. doi: 10.1007/s40629-021-00189-z. Epub 2021 Sep 28.

Abstract

Peanuts are Leguminosae, commonly known as the legume or pea family, and peanut allergy is among the most common food allergies and the most common cause of fatal food reactions and anaphylaxis. The prevalence of peanut allergy increased 3.5-fold over the past two decades reaching 1.4-2% in Europe and the United States. The reasons for this increase in prevalence are likely multifaceted. Sensitization via the skin appears to be associated with the development of peanut allergy and atopic eczema in infancy is associated with a high risk of developing peanut allergy. Until recently, the only possible management strategy for peanut allergy was strict allergen avoidance and emergency treatment including adrenaline auto-injector in cases of accidental exposure and reaction. This paper discusses the various factors that impact the risks of peanut allergy and the burden of self-management on peanut-allergic children and their caregivers.

Keywords: Anaphylaxis; COVID-19; Children; Food allergy; Oral immunotherapy.